UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreMultiple Myeloma: Stem Cell Transplant and Beyond
Presenter: Frits van Rhee MD, PhD, Professor of Medicine and Clinical Director of the UAMS Myeloma Center, University of Arkansas for Medical Sciences
Watch VideoManaging Emotional Challenges after Transplant
Presenter: Harold Dean MSW, LCSW, OSW-C Social Work Program Manager, University of Arkansas for Medical Sciences
Watch VideoMyeloma Center: UAMS Winthrop P. Rockefeller Cancer Institute ‘Be a Part of the Cure’ Telethon Airs Statewide on ABC Sept. 8
Arkansans are invited to “Be a Part of the Cure” on Sept. 8 when the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) holds its second televised event to raise funds and awareness for its cancer research and treatment programs. The event is set for 11 a.m. – 6:30…
News & Announcements
Samer Al Hadidi, M.D., Joins the UAMS Myeloma Center
LITTLE ROCK — Samer Al Hadidi, M.D., has joined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where he will treat patients with myeloma and other plasma cell disorders. “I’m very happy to welcome Dr. Al Hadidi to our staff,” said Frits van Rhee,…
Read more
UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients
The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.
Read more
Riney Foundation Gives $1.8 Million to UAMS Myeloma Center in the Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — The Paula and Rodger Riney Foundation announced a gift of $1.8 million to the University of Arkansas for Medical Sciences (UAMS) Myeloma Center in the Winthrop P. Rockefeller Cancer Institute to fund multiple myeloma research. “Paula and I are pleased to invest in the UAMS Myeloma Center, which has made great strides…
Read more
UAMS Cancer Institute’s Volunteers, Paused by the Pandemic, Ready to Return
(UAMS) The UAMS Winthrop P. Rockefeller Cancer Institute’s nearly 70 volunteers may have been out of sight for more than a year thanks to COVID-19, but they have remained close at heart to the Cancer Institute’s staff. For employees of Cancer Institute’s Volunteer Services and Auxiliary department, time and distance has not diminished their appreciation…
Read moreWant to read more stories like these?